Animal models of ALS

Clinical Neuroscience

Volumn 3, Issue 6, 1995, Pages 375-385

  Pioro, Erik P ^a,b   Mitsumoto, Hiroshi ^a,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Department of Neurology ^*  (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Cu,Zn superoxide dismutase (SOD1); gene knockout; hereditary canine spinal muscular atrophy (HCSMA); motor neuron degeneration (Mnd); neurotoxic; progressive motor neuronopathy (pmn); transgenic mouse; viral; wobbler

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; DIFFERENTIAL DIAGNOSIS; DOG; ENZYME MODIFICATION; GENE MUTATION; HEREDITARY SPINAL MUSCULAR ATROPHY; MOTONEURON; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; DOGS; HUMANS; MICE;

EID: 0029434245     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Alexianu ME, Ho B-K, Mohamed H, La Bella V, Smith RG, Appel SH (1994): The role of calcium-binding proteins in the selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 36:846-858.
2. Anand P, Cedarbaum J, Lindsay RM, Parrett A, Foley P, Martin J, Swash M, Zeman S, Leigh PN (1994): Marked depletion of ciliary neurotrophic factor in ventral horn of spinal cord but not cerebral cortex in amyotrophic lateral sclerosis. Ann Neurol 36:318.
3. Andrews JM, Gardner MB (1974): Lower motor neuron degeneration associated with type C RNA virus infection in mice: Neuropathological features. J Neuropathol Exp Neurol 33:285-307.
4. Andrews JM, Gardner MB, Wolfgram FJ, Ellison GW, Porter DD, Brandkamp WW (1974): Studies on a murine form of spontaneous lower motor neuron degeneration-The wobbler (wr) mouse. Am JPathol 76:63-78.
5. Appel SH, Smith RG, Alexianu M, Siklos L, Engelhardt J, Colom LV, and Stefani E (1996): Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis. Clinical Neuroscience 3:368-374.
6. Baulac M, Rieger F, Meininger V (1983): The loss of motoneurons corresponding to specific muscle in the wobbler mutant mouse. Neurosci Lett 37:99-104.
7. Bizzi A, Crane RC, Autilio-Gambetti L, Gambetti P (1984): Aluminum effect on slow axonal transport: A novel impairment of neurofilament transport: A novel impairment of neurofilament transport. J Neurosci 4:722-731.
8. Blondet B, Barlovatz-Meimon G, Festoff BW, Soria C, Soria J, Rieger F, Hantai D (1992): Plasminogen activators in the neuromuscular system of the wobbler mutant mouse. Brain Res 580:303-310.
9. Bronson RT, Lake BD, Cook ERC, Taylor S, Davisson MT (1993): Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease). Ann Neurol 33:381-385.
10. Callahan LM, Wylen EL, Messer A, Mazurkiewicz JE (1991): Neurofilament distribution is altered in the mnd (motor neuron degeneration) mouse. J Neuropathol Exp Neurol 50:491-504.
11. Chou SM, Hartman HA (1964): Axonal lesions and waltzing syndrome after IDPN administration in rats. Acta Neuropathol 4:428-450.
12. Chou SM, Hartman HA (1965): Electron microscopy of focal neuroaxonal lésions produced by (,'-iminodipropionitrile (IDFN) in rats Acta Neuropath 4:590603.
13. Clark AW, Griffin JW, Price DL (1980): The axonal pathology in chronic IDPN intoxication. J Neuropathol Exp Neurol 39:42-55.
14. Collard J-F, Côté F, Julien J-P (1995): Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375:61-64.
15. Cork LC, Griffin JW, Munnell JF, Lorenz MD, Adams RJ, Price DL (1979): Hereditary canine spinal muscular atrophy. J Neuropathol Exp Neurol 38:209-221.
16. Cork LC, Griffin JW, Choy C, Padula CA, Price DL (1982): Pathology of motor neurons in accelerated hereditary canine spinal muscular atrophy. Lab Invest 46:89-99.
17. Cork LC, Altschuler RJ, Zbruha PJ, Morris JM, Lloyd DG, Loats HL, Griffin JW, Price DL (1989): Changes in neuronal size and neurotransmitter marker in hereditary canine spinal muscular atrophy. Lab Invest 61:69-76.
18. Côté F, Collard, J-F, Julien J-P (1993): Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis. Cell 73: 35-46.
19. Court JA, McCermott JR, Gibson AM, Marshall E, Bloxham CA, Perry RH, Edwardson JA (1987): Raised thyrotrophin-releasing hormone, pyroglutamylamino peptidase, and proline endopeptidase are present in the spinal cord of wobbler mice but not in human motor neurone disease. J Neurochem 49:1084-1090.
20. Dal Canto MC (1996): Comparison of pathological alterations in ALS and a murine transgenic model: Pathogenic implications. Clinical Neuroscience 3: 332-337.
21. Duchen LW, Strich SJ (1968): An hereditary motor neurone disease with progressive denervation of muscle in the mouse: The mutant 'wobbler'. J Neurol' Neurosurg Psychiatry 31:535-542.
22. Duncan MW, Kopin If, Garruto RM, Lavine L,Markey SP (1988): 2-Amino-3 (Methylamino)-Propionic acid in cycad-derived foods is an unlikely cause of amyotrophic lateral sclerosis/parkinsonism. Lancet 2:631-632.
23. Duncan MW (1992): (-Methylamino-Lalanine (BMAA) and amyotrophic lateral sclerosis-parkinsonism dementia of the Western Pacific. Ann NY Acad Sei 648:161-168.
24. Engelhardt J, Joo F (1986): An immunemediated guinea pig model for lower motor neuron disease. J Neuroimmunol 12:279-290.
25. Engelhardt JI, Appel SH, Killian JM (1989): Experimental autoimmune motoneuron disease. Ann Neurol 26:368-376.
26. Engelhardt JI, Appel SH (1990): IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol 47:1210-1216.
27. England JD, Asbury AK, Rhee EK, Sumner AJ (1988): Lethal retrograde axoplasmic transport of doxorubicin (adriamycin) to motor neurons. A toxic motor neuronopathy. Brain 111:915-926.
28. Falconer DS (1956): Wobbler (vvr). Mouse Newsl 15:23.
29. Gardner MB, Henderson BE, Officer JE, Rongey RW, Parker JC, Oliver C, Estes JD, Huebner RJ (1973): A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J Natl Cancer Inst 51:12431254.
30. Garruto RM, Shankar SK, Yanagihara R, Salazar AM, Amyx HL, Gadjusek DC (1989): Low-calcium, high-aluminum diet-induced motor neuron pathology in cynomologus monkeys. Acta Neuropathol 78:210-219.
31. Griffin JW, Huffman PN, Clark AW, Carroll PT, Price DL (1978): Slow axonal transport of neurofilament proteins: Impairment by,'-iminodipropionitrile administration. Science 202:633-635.
32. Griffin JW, Cork LC, Adams RJ, Price DL (1982): Axonal transport in hereditary canine spinal muscular atrophy. J Neurol Neuropathol Exp Neurol 41:370.
33. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng H-X, Chen W, Zhai P, Sufit RL, Siddique T (1994): Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264: 1772-1775.
34. Hantaz-Ambroise D, Blondet B, Murawsky M, Rieger F (1994). Abnormal astrocyte differentiation and defective cellular interactions in wobbler mouse spinal cord. J Neurocytol 23:179-192.
35. Harris JB, Ward MR (1974): A comparative study of "denervation" in muscles from mice with inherited progressive neuromuscular disorders. Exp Neurol 42:169-180.
36. Helgren ME, Friedman B, Kennedy M, Mullholland K, Messer A, Wong V, Lindsay RM (1992): Ciliary neurotrophic factor (CNTF) delays motor impairments in the Mnd mouse. A genetic model for motor neuron disease. Soc Neurosci Abs 18:618.
37. Hugon J, Ludolph A, Roy DN, Schaumburg HH, Spencer PS (1988): Clinical and electrophysiologic features of pyramidal dysfunction in macaques fed Lathyrus sativus and 1DPN. Neurology 38: 435-442.
38. Ikeda K, Mitsumoto H (1993): In vivo and in vitro muscle tension in wobbler mouse motor neuron disease. Muscle Nerve 16:979-981.
39. Jolicoeur P (1990): Retrovirus-induced lower motor neuron disease in mice: a model for amyotrophic lateral sclerosis and human spongiform neurological disease. In Hudson AJ (ed): Amyotrophic Lateral Sclerosis. Toronto: University Toronto Press, pp 53-75.
40. Jubelt B, Meagher JB (1984): Poliovirus infection of cyclophosphamide-treated mice results in persistence and late paralysis. I. Clinical, pathologic, and immunologie studies. Neurology 34:486493.
41. Junier MP, Coulpier M, LeForestier N, Cadusseau J, Suzuki F, Peschanski M, Dreyfus PA (1994): Transforming growth factor alpha (TGF() expression in degenerating motor neurons of the murine mutant wobbler: a neuronal signal for astrogliosis? J Neurosci 14:4206-4216.
42. Kaupmann K, Simon-Chazottes D, Guénet J-L, Jockusch H (1992): Wobbler, a mutation affecting motoneuron survival and gonadal functions in the mouse, maps to proximal chromosome 11. Genomics 13:39-43.
43. Kohn R (1971) Clinical and pathological findings in an unusual infantile motor neuron disease. J Neurol Neurosurg Psychiatry 34:427-431.
44. Kozachuk WE, Mitsumoto H, Salanga VD, Beck GJ, Wilber JF (1987): Effects of daily TRH administration in murine motor neuron disease (wobbler mouse). J Neurol Sei 78:253-260.
45. Krieger C, Perry TL, Hansen S, Mitsumoto (1991): The wobbler mouse: amino acid contents in brain and spinal cord. Brain Res 551:142-144.
46. Krieger C, Perry TL, Hanson S, Mitsumoto H, Honore T (1992): Excitatory amino acid receptor antagonists in murine motor neuron disease. Can J Neurol Sei 19:462-465.
47. Krieger C, Lai R, Mitsumoto H, Shaw C (1993): The wobbler mouse: quantitative autoradiography of glutamatergic ligand binding sites in spinal cord. Neurogeneration 2:9-17.
48. 'Laage S, Zobel G, Jockusch H (1988): Astrocyte overgrowth in the brain stem and spinal cord of mice affected by spinal atrophy, wobbler. Dev Neurosci 10:190-198.
49. Lange DJ, Good PF, Bradley WG (1983): A therapeutic trial of gangliosides and thymosin in the wobbler mouse model of motor neuron disease. J Neurol Sei 61:211-216.
50. LaVail JH, Koo EH, Dekker NP (1987). Motoneuron loss in the abducens nucleus of wobbler mice. Brain Research 404:127-132.
51. LaVail JH, Koo EH, Irons KP (1988): Abnormal neuromuscular junctions in the lateral rectus muscle of wobbler mice. Brain Res 463:78-89.
52. Lee MK, Marszalek JR, Cleveland DW (1994): A mutant neurofilament subunit causes massive selective motor neuron death: Implications for the pathogenesis of human motor neuron disease. Neuron 13:975-988.
53. Ma W, Vacca-Galloway LL (1991) Reduced branching and length of dendrites detected in cervical spinal cord motoneurons of wobbler mouse, a model for inherited motoneuron disease. J Comp Neurol 311:210-222.
54. Ma W, Vacca-Galloway LL (1992) Spiny interneurons identified in the normal mouse spinal cord show alterations in the Wobbler mouse: A model for inherited motoneuron disease. Restor Neurol Neurosci 4:381-392.
55. Mandler R, Baba JM (1992): Muscle lactate dehydrogenase activity is decreased in murine motor neuron disease. Brain Res 576:337-338.
56. Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen H (1993): Disruption of the CNTF gene results in motor neuron degeneration. Nature 365: 27-32.
57. Mazurkiewica JE (1991): Ubiquitin deposits are present in spinal motor neurons in all states of the disease in the motor neuron degenerations. Neurosci Lett 128:182-186.
58. Messer A, Flaherty L (1986): Autosomal dominance in a late-onset motor neuron disease in the mouse. J Neurogenet 3:345-355.
59. Messer A, Strominger NL and Mazurkiewicz JE (1987): Histopathology of the late-onset motor neuron degeneration (Mnd) mutant in the mouse. J Neurogen 4:201-213.
60. Messer A, Plummer T., Maskin P, Coffin JM, Frankel WN (1992): Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS). Genomics 18:797-802.
61. Messer, A (1994): Animal models of amyotrophic lateral sclerosis. In Smith RA (ed): Handbook of Amyotrophic Lateral Sclerosis. New York: Marcel Dekker, pp 433-451.
62. Miller JR (1981): Prolonged intracerebral infection with poliovirus in asymptomatic mice. Ann Neurol 9:590-596.
63. Mitsumoto H, Bradley VVG (1982): The murine motor neuron disease (the wobbler mouse): degeneration and regeneration of the lower motor neuron. Brain 105:811-834.
64. Mitsumoto H (1985): Axonal regeneration in murine motor neuron disease. Muscle Nerve 8:44-51.
65. Mitsumoto H, Bradley VVG (1985): Axonal pathology in the murine motor neuron disease. In Adachi M, Hirano A, Aronson G (eds): Current Trends in Neuroscience. Vol. 3 New York: Igaku-Shoin, pp 126-149.
66. Mitsumoto H, Gambetti P (1986): Impaired slow axonal transport in wobbler mouse motor neuron disease. Ann Neurol 19:64-68.
67. Mitsumoto H, Boggs AL (1987): Vacuolated anterior horn cells in wobbler mouse motor neuron disease: peripheral axons and regenerative capacity. J Neuropathol Exp Neurol 46:214-222.
68. Mitsumoto H (1988): Study of motor neuron disease. An approach with an animal model (the wobbler mouse). In Daroff RB, Conomy JP (eds): Contributions to Contemporary Neurology: A Tribute to Joseph M. Foley, M.D. Stoneham: Butterworth, pp 127-142.
69. Mitsumoto H, Ferut AL, Kurahasi K, McQuarrie IG (1990a): Impairment of retrograde axonal transport in wobbler mouse motor neuron disease. Muscle Nerve 13:121-126.
70. Mitsumoto H, McQuarrie IG, Karuhashi K, Sunohara N (1990b): Histometric and functional characteristics in the subclinical system of wobbler mouse motor neuron disease. Brain 113:497-508.
71. Mitsumoto H, Kurahashi K, Jacob JM, McQuarrie IG (1993): Retardation of fast axonal transport in wobbler mice. Muscle Nerve 16:542-547.
72. Mitsumoto H, Ikeda K, Holmlund T, Greene T, Cedarbaum JM, Wong V, Lindsay RM (1994a): The effects of ciliary neuro-trophic factor in wobbler mouse motor neuron disease. Ann Neurol 6:142-148.
73. Mitsumoto H, Ikeda K, Klinlosz B, Cedarbaum JM, Wong V, Lindsay RM (1994b): Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 265:1107-1110.
74. Mizutani T, Aki M, Shiozawa R, Unakami M, Nozawa T, Yajima K, Tanabe H, Hara M (1990): Development of ophthalmoplegia in amyotrophic lateral sclerosis during long-term use of respirators. J Neurol Sei 99:311-319.
75. Murakami T, Mastaglia FL, Bradley WG (1980): Reduced protein synthesis in spinal anterior horn neurons in wobbler mouse mutant. Exp Neurol 67:423-432.
76. Murakami T, Mastagglia FL, Mann DM, Bradley WG (1981): Abnormal RNA metabolism in spinal motor neurons in the wobbler mouser. Muscle Nerve 4:407-412.
77. Papapetropoulos TA, Bradley WG (1972): Spinal motor neurones in murine muscular dystrophy and spinal muscular atrophy. J Neurol Neurosurg Psychiat 35:60-65.
78. Pollin MM, McHanwell, Slater CR (1990): Loss of motor neurons from the median nerve motor nucleus of the mutant mouse 'wobbler.' J Neurocytol 19:29-38.
79. Price DL, Cleveland DW, Koliatsos VE (1994): Motor neurone disease and animal models. Neurobiol Dis 1:3-11.
80. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng H-X, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung W-Y, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH Jr (1993): Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
81. Sack GH, Cork LC, Morris JM, Griffin JW, Price DL (1984): Autosomal dominant inheritance of hereditary canine spinal muscular atrophy. Ann Neurol 15:369-373.
82. Schmalbruch H, Jensen H-J S, Bjaerg M, Kamieniecka Z, Kurland L (1991): A new mouse mutant with progressive motor neuronopathy. J Neuropathol Exp Neurol 50:192-204.
83. Sellevis Smitt PAE, de Jong JMBV (1989): Animal models of amyotrophic lateral sclerosis and the spinal muscular atrophies. J Neurol Sei 91:231-258.
84. Sendtner M, Schmalbruch H, Stöckli KA, Carroll P, Kreutzberg GW, Thoenen H (1992a): Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358:502-504.
85. Sendtner M, Stöckli KA, Carroll P, Kreutzberg GW, Thoenen H, Schmal-bruch H (1992b): More on motor neurons. Nature 360:541-542.
86. Smith RG, Engelhardt JI, Tajti E., Appel SH (1993): Experimental immune-mediated motor neuron diseases: Models for human ALS. Brain Res Bull 30:373-380.
87. Spencer PS, Schaumburg HH (1981): Classification of neurotoxic disease: A morphological approach. In Spencer PS, Schaumburg HH (eds): Experimental and clinical neurotoxicology. Baltimore: Williams & Wilkins, pp 92-101.
88. Spencer PS, Ludolph A, Dvvivedi MP, Roy DN, Hugon J, Schaumburg HH (1986): Lathyrism: Evidence for role of the neuroexcitatory amino acids BOAA. Lancet 2:1066-1077.
89. Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Roy DN, Robertson RC (1987): Guam amyotrophic lateral sclerosis-Parkinsonism dementia linked to a plant excitant neurotoxin. Science 237: 517-522.
90. Strong MJ, Garruto RM (1991): Chronic aluminum-induced motor neuron degeneration: Clinical, neuropathological and molecular biological aspects. Can J Neurol Sei 18:428-131.
91. Strong MJ, Garruto RM (1994): Experimental paradigms of motor neuron degeneration. In Woodruff ML, Nonneman AJ (eds): Toxin-induced Models of Neurological Disorders. New York: Plenum Press, pp 39-88.
92. Tang F, Cheung A, Vacca-Galloway LL (1990): Measurement of neuropeptides in the brain and spinal cord of wobbler mouse: a model for motoneuron disease. Brain Res 518:329-333.
93. Troncoso JC, Price DL, Griffin JW, Parhad IM (1982): Neurofibrillary axonal pathology in aluminum intoxication. Ann Neurol 12:278-283.
94. Vacca-Galloway LL, Steinberger CC (1986): Substance P neurons sprout in the cervical spinal cord of the wobbler mouse: a model for motoneuron disease. J Neurosci Res 16:657-670.
95. Vrbovâ G, Greensmith L, Sleradzan K (1992): Motor neuron disease model. Nature 358:502-504.
96. Westarp ME, Westphal KP, Clausen J, Rasmussen HB, Hoff-Jorgensen R, Fohring B, Kornhuber HH (1993): Retroviral interference with neuronotrophic signalling in human motor neuron disease? Clin Physiol Biochem 10:1-7.
97. Wichmann H, Jockusch H, Guénet J-L, Gallwitz D, Kaupmann K (1992): The mouse homolog to the ras-related yeast YPT1 maps on chromosome 11 close to the wobbler (wr) locus. Mammal Genome 3:467-468.
98. Yase Y (1984): Metal metabolism in motor neuron disease. In Chen K-M, Yase Y (eds): Amyotrophic Lateral Sclerosis in Asia and Oceania. Taipei, Taiwan: National Taiwan University Press, pp 337-356.